Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethinyl Estradiol + Cyproterone Acetate in Irregular Menstruation
NCT01103518Phase 4Unknown
- Sponsor
- Fundação Educacional Serra dos Órgãos
- Start
- Dec 2009
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ethinyl estradiol + cyproterone in hyperandrogenism and menstrual disorder (2 arms), sponsored by Fundação Educacional Serra dos Órgãos. Primary endpoint: Regular Menstruation at 3 months. Status: unknown.
02
Drugs
ethinyl estradiol + cyproterone
03
Conditions
hyperandrogenismmenstrual disorder
Beyond the preview
Go deeper on NCT01103518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103518.